18 results
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
, portfolio sustainability, business development and financial targets. The board of directors, upon recommendation of the compensation committee, determines … and parity in targets among executives in roles of a given level. For 2022, our compensation committee reviewed competitive market data prepared
8-K
EX-99.2
3itj7axmstq0o62 y8i
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
424B4
3ajz1jr4
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
5srvv5ekp6uk6et27xxc
23 Jan 19
IPO registration (amended)
4:39pm
S-1
EX-10.8
lvf8k83kurrzb8w8u
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.1
s608t0u2pdv0xpndk01p
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.9
pgc02bxnj xa
21 Dec 18
IPO registration
4:39pm
S-1
6f9tw37gofrq59rp2a79
21 Dec 18
IPO registration
4:39pm
DRS/A
45uh gyeszzoyy5i6i
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
wyii5m8
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.9
lbzb4gj c08peh1ox3m
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.1
3l0mcnauz4e
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.8
xgouatni4eg6akj
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next